bionanogenomics.com (BNGO) Narx-foyda multiplikatori

Bionano - BNGO emitenti grafik logotipi

Geopolitik beqarorlik va sanksiyalar DNK tahlil tizimlari global savdosini hamda xalqaro ilmiy almashinuvni jiddiy ravishda to'sqinlayapti. Bionano Genomics, Inc. (BNGO) qimmatli qog'ozlarining bozor dinamikasi -0.50 miqdoridagi PE koeffitsiyentini aks ettiradi. Eksklyuziv patentlar va AQSh qo'llab-quvvatlashi biznes uchun himoya vazifasini o'taydi, garchi FDA ning qat'iy nazorati operatsiyalarni murakkablashtirsa-da. Shu bilan birga, Bionano Genomics, Inc. (BNGO) likvidlik tanqisligi va yuqori operatsion xarajatlardan aziyat chekmoqda.

Bionano Genomics (BNGO): Narxning foydaga nisbati 04.07.2022dan 16.11.2026gacha

bionanogenomics.com (BNGO) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning jamlanma tahlili:BNGO - Bionano Genomics
Bionano Genomics, Inc. original mahsuloti

P/E ko'rsatkichi sof foydaning bir birligining bozor qiymatini o'lchaydi va investitsiyalarning qoplanish muddatini belgilaydi. Bionano Genomics, Inc. (BNGO) uchun ushbu hisob-kitob murakkab genom xaritalash tizimlarini yig'ish jarayonidagi operatsion marjalarga bog'liq. Biznesning joriy P/E ko'rsatkichi -0.50 bo'lib, bu o'sish sur'atlariga nisbatan bozor kutganlarini aks ettiradi. Ushbu qiymatning dinamikasi logistika xarajatlari fonida haddan tashqari ko'p to'lov qilish xavfini baholashga yordam beradi. Investor uchun ushbu koeffitsiyentni aktivning likvidligi bilan solishtirish juda muhimdir.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti TSHA|QURE - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori MGTX|Biznesning o‘zini qoplash muddati regenxbio.com|P/E multiplikatori SLDB (Solid Biosciences Inc)|OCGN: Narx-foyda multiplikatori|PACB - Narxning foydaga nisbati|Benitec (BNTC) - Narx-foyda koeffitsiyenti|DSGN: P/E multiplikatori|RCKT: Bozor narxining sof foydaga nisbati|FDMT (4D Molecular Therapeutics, Inc.) - P/E multiplikatori|lexeotx.com (LXEO) - Biznesning o‘zini qoplash muddati|P/E multiplikatori KRRO|Narx-foyda koeffitsiyenti Editas Medicine, Inc. EDIT|Narxning foydaga nisbati silence-therapeutics.com SLN|PRQR: Narx-foyda multiplikatori|CDXS - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Metagenomi, Inc. (MGX)|Narx-foyda koeffitsiyenti DTIL|Narx-foyda multiplikatori GBIO (generationbio.com)|Narxning foydaga nisbati Boundless Bio, Inc (BOLD)|P/E multiplikatori Exicure Inc. (XCUR)|Imunon, Inc. - Narx-foyda koeffitsiyenti|PHIO: Narx-foyda multiplikatori|MBIO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati RNAZ|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati